293b cpd has been researched along with Myocardial Infarction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, A; Becker, R; Freigang, KD; Kraft, P; Kuebler, W; Schoels, W; Senges, JC; Voss, F | 1 |
1 other study(ies) available for 293b cpd and Myocardial Infarction
Article | Year |
---|---|
Electrophysiologic effects of the new I(Ks)-blocking agent chromanol 293b in the postinfarction canine heart. Preserved positive use-dependence and preferential prolongation of refractoriness in the infarct zone.
Topics: Animals; Chromans; Dogs; Heart; Myocardial Infarction; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sulfonamides | 2000 |